scPharmaceuticals

$8.54
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.05 (-0.57%) Today
-$0.20 (-2.29%) As of 8:00 PM EST after-hours

Why Robinhood?

You can buy or sell SCPH and other stocks, options, and ETFs commission-free!

About SCPH

scPharmaceuticals, Inc.engages in the development of transformative pharmaceutical products for subcutaneous delivery. Its products include furosemide, used as parenteral diuretic in treating heart failure and ceftriaxone, used as parenteral antibiotic outside the hospital setting. The company was founded by Pieter Muntendam and Bertram Pitt in February 2013 and is headquartered in Burlington, MA. The listed name for SCPH is scPharmaceuticals Inc. Common Stock.

CEO
John H. Tucker
Employees
17
Headquarters
Burlington, Massachusetts
Founded
2013
Market Cap
238.79M
Price-Earnings Ratio
Dividend Yield
Average Volume
48.52K
High Today
$9.01
Low Today
$8.62
Open Price
$8.92
Volume
76.82K
52 Week High
$11.99
52 Week Low
$4.01

Collections

SCPH Earnings

-$0.58
-$0.39
-$0.19
$0.00
Q1 FY19
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
per share
Actual
Expected Mar 24, Pre-Market

You May Also Like